| Insider | Role | Shares | Value | Buys | Sells |
|---|---|---|---|---|---|
| Date | Ticker | Insider | Role | Type | Shares | Price | Value | Chg% | SEC |
|---|---|---|---|---|---|---|---|---|---|
| Insider | Role | Shares | Value | Buys | Sells |
|---|---|---|---|---|---|
| Date | Ticker | Insider | Role | Type | Shares | Price | Value | Chg% | SEC |
|---|---|---|---|---|---|---|---|---|---|
Director
5 companies
Sato Vicki L is a Director at Vir Biotechnology, Inc. with holdings across 5 companies. Recent SEC Form 4 filings include 0 buys and 26 sells.
Estimated insider holdings value: $17.9M based on current market prices.
| Date | Ticker | Role | Type | Shares | Price | Value | Chg% | 3M | 12M | SEC |
|---|---|---|---|---|---|---|---|---|---|---|
| Aug 19, 2021 | VIR Vir Biotechnology, Inc. | Director | Sell | 15,174 | $45.05 | $683,610.84 | -0.5% | -25.4% | -45.4% | |
| Aug 18, 2021 | DNLI Denali Therapeutics Inc. | Director | Sell | 1,666 | $51.70 | $86,138.76 | -0.6% | -0.9% | -32.2% | |
| Jul 21, 2021 | DNLI Denali Therapeutics Inc. | Director | Sell | 1,666 | $65.13 | $108,509.84 | -0.4% | -32.3% | -43.2% | |
| Jul 19, 2021 | VIR Vir Biotechnology, Inc. | Director | Sell | 15,174 | $37.20 | $564,509.04 | -0.5% | +0.2% | -24.3% | |
| Jun 23, 2021 | DNLI Denali Therapeutics Inc. | Director | Sell | 1,666 | $70.74 | $117,844.85 | -0.6% | -25.1% | -57.5% | |
| Jun 21, 2021 | VIR Vir Biotechnology, Inc. | Director | Sell | 15,174 | $46.17 | $700,515.08 | -0.5% | +1.2% | -49.7% | |
| May 26, 2021 | DNLI Denali Therapeutics Inc. | Director | Sell | 1,666 | $65.37 | $108,911.49 | -0.4% | -19.3% | -62.8% | |
| May 19, 2021 | VIR Vir Biotechnology, Inc. | Director | Sell | 15,174 | $43.80 | $664,600.62 | -0.3% | -4.8% | -43.3% | |
| Apr 28, 2021 | DNLI Denali Therapeutics Inc. | Director | Sell | 1,666 | $62.15 | $103,538.44 | -0.4% | -22.5% | -60.4% | |
| Mar 31, 2021 | DNLI Denali Therapeutics Inc. | Director | Sell | 1,666 | $56.42 | $93,992.04 | -0.3% | +34.6% | -43.7% |